bioimagesUnknownYuting SunThe Journal of Cell Biologyhttps://www.ebi.ac.uk/biostudies/studies/S-JCBD-200912093JCB

H&E staining of cross-sectin of mouse TA muscle under regeneration, day 14 post damage, vehicle treated.

MHC (Green) and DAPI (Blue) staining of anti-miR-1 transfected, follistatin treated C2C12 cells.<br />

MHC (Green) and DAPI (Blue) staining C2C12 cells.

H&E staining of cross-sectin of mouse TA muscle under regeneration, day 7 post damage, vehicle treated.

MHC (Green) and DAPI (Blue) staining of IGFII, Rapamycin and follistatin treated C2C12 cells.<br />

MHC (Green) and DAPI (Blue) staining of anti-miR-1 transfected C2C12 cells.<br />

Fig S3_miR-1 probe_vehicle<br />ISH with miR-1 probe, cross-section of mouse TA muscle under regeneration, vehicle treated.

MHC (Green) and DAPI (Blue) staining of anti-miR-1 transfected, TSA treated C2C12 cells.<br />

MHC (Green) and DAPI (Blue) staining of C2C12 cells stably expressing Flag-mTOR RR/KI (Rapamycin-resistant, kinase-inactive) mutant, treated with Rapamycin and TSA.

H&E staining of cross-sectin of mouse TA muscle under regeneration, day 14 post damage, Rapamycin and TSA treated.

MHC (Green) and DAPI (Blue) staining of a scrambled oligo transfected C2C12 cells.

MHC (Green) and DAPI (Blue) staining of C2C12 cells stably expressing Flag-mTOR RR/KI (Rapamycin-resistant, kinase-inactive) mutant, treated with Rapamycin.

H&E staining of cross-sectin of mouse TA muscle under regeneration, day 14 post damage, Rapamycin treated.

Fig S3_miR-1 probe_Rap<br />ISH with miR-1 probe, cross-section of mouse TA muscle under regeneration, rapamycin treated.<br />

Fig S3_scramble probe_vehicle<br />ISH with scrambled probe, cross-section of mouse TA muscle under regeneration, vehicle treated.<br />

MHC (Green) and DAPI (Blue) staining of C2C12 cells stably expressing Flag-mTOR RR/KI (Rapamycin-resistant, kinase-inactive) mutant, treated with Rapamycin and follistatin.

H&E staining of cross-sectin of mouse TA muscle under regeneration, day 1 post damage, vehicle treated.

Fig S3_enlarged panel_miR-1 and DAPI<br />overlay image of miR-1 ISH (blue) and DAPI (green), cross-section of mouse TA muscle under regeneration, vehicle treated.<br />

MHC (Green) and DAPI (Blue) staining of IGFII and Rapamycin treated C2C12 cells.

MHC (Green) and DAPI (Blue) staining of C2C12 cells stably expressing Flag-mTOR RR/KI (Rapamycin-resistant, kinase-inactive) mutant, treated with Rapamycin and conditioned media.

H&E staining of cross-sectin of mouse TA muscle under regeneration, day 14 post damage, Rapamycin and follistatin treated.

bioimagesImage 10654 (Figure 6 - B)Image 10656 (Figure 9 - A)Image 17718 (SupFigure 3 - None)Figure 10 - BSupFigure 3 - NoneImage 10725 (Figure 10 - B)Image 10722 (Figure 10 - B)SupFigure 3Figure 9 - BFigure 9 - AImage 10653 (Figure 6 - B)Image 17715 (SupFigure 3 - None)Image 10721 (Figure 9 - B)Image 17716 (SupFigure 3 - None)Image 10723 (Figure 10 - B)Image 10726 (Figure 10 - B)Image 10658 (Figure 9 - A)Image 10652 (Figure 6 - B)Image 10733 (Figure 9 - B)Image 10718 (Figure 9 - B)Figure 6Image 10655 (Figure 6 - B)Figure 10Image 10724 (Figure 10 - B)Figure 9Image 10657 (Figure 9 - A)Image 17717 (SupFigure 3 - None)Image 10727 (Figure 10 - B)Figure 6 - BImage 10719 (Figure 9 - B)Yuting SunJenny DrnevichYong ZhaoJie ChenYejing GeMark BandfalseMammalian target of rapamycin regulates miRNA-1 and follistatin in skeletal myogenesis2010-06-21T11:19:34Z2018-11-29T11:19:34Z2018-11-29T11:19:34ZS-JCBD-20091209310.1083/jcb.200912093